Ditchcarbon
  • Contact
  1. Organizations
  2. Galderma S.A.
Public Profile
Pharmaceutical Preparation Manufacturing
CH
updated 2 months ago

Galderma S.A. Sustainability Profile

Company website

Galderma S.A., a leading global dermatology company headquartered in Switzerland (CH), has been at the forefront of skin health since its establishment in 1981. With a strong presence in major operational regions including Europe, North America, and Asia, Galderma focuses on innovative solutions in dermatology, offering a diverse portfolio that encompasses prescription products, aesthetic treatments, and consumer skin care. Renowned for its flagship brands such as Restylane and Cetaphil, Galderma distinguishes itself through a commitment to scientific research and development, ensuring high-quality, effective products tailored to various skin concerns. The company has achieved significant milestones, including numerous regulatory approvals and a robust market position, making it a trusted name in the dermatological field. With a dedication to enhancing skin health, Galderma continues to lead advancements in dermatological care worldwide.

DitchCarbon Score

How does Galderma S.A.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

40

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

34

Industry Benchmark

Galderma S.A.'s score of 40 is higher than 59% of the industry. This can give you a sense of how well the company is doing compared to its peers.

59%

Let us know if this data was useful to you

Galderma S.A.'s reported carbon emissions

Inherited from Galderma Group AG

Galderma S.A., headquartered in Switzerland (CH), currently does not report specific carbon emissions data, as indicated by the absence of emissions figures in kg CO2e. The company is a current subsidiary of Galderma Group AG, which may influence its climate-related initiatives and commitments. Despite the lack of direct emissions data, Galderma S.A. is part of a broader corporate family that may have established climate commitments. However, no specific reduction targets or initiatives have been documented for Galderma S.A. at this time. The absence of data suggests that the company may still be in the process of developing its climate strategy or reporting framework. As a subsidiary, Galderma S.A. may align its environmental goals with those of its parent company, Galderma Group AG, but specific details on emissions reduction targets or climate pledges are not available. The company’s commitment to sustainability and climate action remains unclear without concrete data or defined initiatives.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

20222023
Scope 1
9,800,000
0,000,000
Scope 2
4,200,000
000,000
Scope 3
-
000,000,000

How Carbon Intensive is Galderma S.A.'s Industry?

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Galderma S.A.'s primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

How Carbon Intensive is Galderma S.A.'s Location?

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Galderma S.A. is in CH, which has a very low grid carbon intensity relative to other regions.

Galderma S.A.'s Climate Goals (2030 & 2050)

Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.

Galderma S.A. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Compare Galderma S.A.'s Emissions with Industry Peers

Genesis Biosystems, Inc.

US
•
Medical, precision and optical instruments, watches and clocks (33)
Updated 4 days ago

Johnson & Johnson Consumer Companies, Inc.

US
•
Health and social work services (85)
Updated 2 months ago

Merz Pharma GmbH & Co. KGaA

DE
•
Pharmaceutical Preparation Manufacturing
Updated 17 days ago

Johnson & Johnson Inc.

CA
•
Health and social work services (85)
Updated 2 months ago

Kao USA Inc.

US
•
Chemicals nec
Updated about 1 month ago

PMGC Holdings Inc.

US
•
Chemicals nec
Updated 17 days ago

Let us know if this data was useful to you

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v251119.1
[email protected]+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
UL Solutions verification badge
CDP logo
Gartner Cool Vendor 2025 badge
Available onAWS Marketplace logo
ProductPortalScope 3 Tool FunctionalityDataIntegrationsPricing
CustomersHaleonGrant ThorntonHikmaRead all stories
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesCalculation MethodologyDocumentationBlogFAQOrganizationsIndustriesSBTI APITrust CentreChangelog
AboutTeamCareersLicense AgreementPrivacy